|Send to printer »|
GEN Exclusives: January 11, 2018
Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
<p> The patent covers a specific regimen of preconditioning chemotherapy drugs that is used prior to treatment with adoptive T-cell therapies.</p>
To enjoy more articles like this from GEN, click here to subscribe now!
© 2018 Genetic Engineering & Biotechnology News, All Rights Reserved